Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients
出版年份 2022 全文链接
标题
Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients
作者
关键词
-
出版物
Alzheimers Research & Therapy
Volume 14, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-03-30
DOI
10.1186/s13195-022-00990-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis
- (2021) Bruna Bellaver et al. NEUROLOGY
- Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease
- (2021) Anna H. Boerwinkle et al. NEUROLOGY
- Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
- (2021) Claudia Cicognola et al. Alzheimers Research & Therapy
- Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau
- (2021) Shorena Janelidze et al. Alzheimers & Dementia
- Biomarkers for neurodegenerative diseases
- (2021) Oskar Hansson NATURE MEDICINE
- Developing the ATX(N) classification for use across the Alzheimer disease continuum
- (2021) Harald Hampel et al. Nature Reviews Neurology
- Phenotyping Alzheimer's disease with blood tests
- (2021) Kaj Blennow SCIENCE
- Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
- (2021) Shorena Janelidze et al. JAMA Neurology
- CSF p-tau/Aβ42 ratio and brain FDG-PET may reliably detect MCI “imminent” converters to AD
- (2020) Roberto Santangelo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- (2020) Shorena Janelidze et al. Nature Communications
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
- (2020) Inge M. W. Verberk et al. Alzheimers Research & Therapy
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Determining clinically meaningful decline in preclinical Alzheimer disease
- (2019) Philip S. Insel et al. NEUROLOGY
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia
- (2019) Ganna Blazhenets et al. JOURNAL OF NUCLEAR MEDICINE
- Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
- (2019) Ingrid S van Maurik et al. LANCET NEUROLOGY
- Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
- (2018) David A. Wolk et al. JAMA Neurology
- Practice guideline update summary: Mild cognitive impairment
- (2017) Ronald C. Petersen et al. NEUROLOGY
- Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
- (2017) Lutz Frölich et al. Alzheimers Research & Therapy
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Classification and Epidemiology of MCI
- (2013) Rosebud Roberts et al. CLINICS IN GERIATRIC MEDICINE
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Patch-based segmentation using expert priors: Application to hippocampus and ventricle segmentation
- (2010) Pierrick Coupé et al. NEUROIMAGE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started